Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06269653 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Measuring Protein Turnover in Humans Across the Lifespan by Metabolic Labeling With Deuterium Oxide

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

The 50 most recent of 206 record versions are accounted for below. See every version on ClinicalTrials.gov ↗

  1. Notable Primary and study completion dates: Mar 1, 2026 to Mar 1, 2027v206
  2. Minor 5 versions Re-verified since Jan 29, 2025, no change to tracked fieldsv201-v205
  3. Minor Study description shortened, about 31 wordsv200 See this version in full on ClinicalTrials.gov ↗
  4. Minor Start date changed from estimate of Jan 16, 2025 to Jun 26, 2024 Secondary endpoints: details revised at 1 of 1 entryv199 Show 1 more changeShow less
    • Secondary endpoints: details revised at 1 of 1 entry
  5. Minor Start date: Jan 15, 2025 to Jan 16, 2025v198
Show 41 earlier versionsHide 41 earlier versions
  1. Minor Start date: Jan 14, 2025 to Jan 15, 2025v197
  2. Minor Start date: Jan 13, 2025 to Jan 14, 2025v196
  3. Minor Start date: Jan 12, 2025 to Jan 13, 2025v195
  4. Minor Start date: Jan 9, 2025 to Jan 12, 2025v194
  5. Minor Start date: Jan 8, 2025 to Jan 9, 2025v193
  6. Minor Start date: Jan 6, 2025 to Jan 8, 2025v192
  7. Minor Start date: Jan 5, 2025 to Jan 6, 2025v191
  8. Minor Start date: Jan 2, 2025 to Jan 5, 2025v190
  9. Minor Start date: Jan 1, 2025 to Jan 2, 2025v189
  10. Minor Start date: Dec 26, 2024 to Jan 1, 2025v188
  11. Minor Start date: Dec 25, 2024 to Dec 26, 2024v187
  12. Minor Start date: Dec 24, 2024 to Dec 25, 2024v186
  13. Minor Start date: Dec 22, 2024 to Dec 24, 2024v185
  14. Minor Start date: Dec 19, 2024 to Dec 22, 2024v184
  15. Minor Start date: Dec 18, 2024 to Dec 19, 2024v183
  16. Minor Start date: Dec 17, 2024 to Dec 18, 2024v182
  17. Minor Start date: Dec 9, 2024 to Dec 17, 2024v181
  18. Minor Start date: Dec 8, 2024 to Dec 9, 2024v180
  19. Minor Start date: Dec 5, 2024 to Dec 8, 2024v179
  20. Minor Start date: Dec 2, 2024 to Dec 5, 2024v178
  21. Minor Start date: Dec 1, 2024 to Dec 2, 2024v177
  22. Minor Start date: Nov 28, 2024 to Dec 1, 2024v176
  23. Minor Start date: Nov 26, 2024 to Nov 28, 2024v175
  24. Minor Start date: Nov 25, 2024 to Nov 26, 2024v174
  25. Minor Start date: Nov 24, 2024 to Nov 25, 2024v173
  26. Minor Start date: Nov 21, 2024 to Nov 24, 2024v172
  27. Minor Start date: Nov 20, 2024 to Nov 21, 2024v171
  28. Minor Start date: Nov 19, 2024 to Nov 20, 2024v170
  29. Minor Start date: Nov 18, 2024 to Nov 19, 2024v169
  30. Minor Start date: Nov 17, 2024 to Nov 18, 2024v168
  31. Minor Start date: Nov 14, 2024 to Nov 17, 2024v167
  32. Minor Start date: Nov 13, 2024 to Nov 14, 2024v166
  33. Minor Start date: Nov 12, 2024 to Nov 13, 2024v165
  34. Minor Start date: Nov 11, 2024 to Nov 12, 2024v164
  35. Minor Start date: Nov 10, 2024 to Nov 11, 2024v163
  36. Minor Start date: Nov 7, 2024 to Nov 10, 2024v162
  37. Minor Start date: Nov 5, 2024 to Nov 7, 2024v161
  38. Minor Start date: Nov 4, 2024 to Nov 5, 2024v160
  39. Minor Start date: Nov 3, 2024 to Nov 4, 2024v159
  40. Minor Start date: Oct 31, 2024 to Nov 3, 2024v158
  41. Minor Start date: Oct 30, 2024 to Oct 31, 2024v157
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Background: Proteins are essential to the health and structure of the cells that make up body tissues. Most proteins become damaged over time and are replaced with new ones. This process is called "protein turnover." Stress, disease, and aging can affect this process. Researchers want to better understand how aging affects protein turnover. Objective: To measure rates of protein turnover in healthy adults. Eligibility: Healthy people aged 20 years and older with a body mass index between 20 and 30. Design: Participants will have 6 study visits over 4 to 6 weeks. They will fast 12 hours before each visit. Participants will be screened. They will have a physical exam, with blood and urine tests and tests of their heart function. They will lie down while blood pressure cuffs are used on their arms and legs. Participants will be given bottles of heavy water to drink at home on a schedule for 21 days. Each bottle holds about 3.5 tablespoons. Heavy water is odorless, colorless, and tasteless, like normal drinking water. It is safe to drink and has been used in research for many years. Participants will have tests during study visits, including: Imaging scans of a leg. Exercise on a treadmill. Biopsies of muscle, skin, and fat: Small samples of tissue will be cut from the calf and abdomen. Resting metabolic rate: Participants will lie still and breathe into a mask for 20 minutes. Knee/grip strength: Participants will do strength tests with their legs. They will squeeze a device with their hands. D3-Creatine: Participants will take 1 pill of D3-Creatine, which occurs naturally in muscle.
Trial Details
NCT Number NCT06269653
Lead Sponsor National Institute on Aging (NIA)
Conditions Healthy Volunteers
Enrollment 75 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov